Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3

Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3

Bibliographic Details
Main Authors: Colombel, Jean-Frederic, Sandborn, William J, Ghosh, Subrata, Wolf, Douglas C, Panaccione, Remo, Feagan, Brian, Reinisch, Walter, Robinson, Anne M, Lazar, Andreas, Kron, Martina, Huang, Bidan, Skup, Martha, Thakkar, Roopal B
Format: Online
Language:English
Published: Nature Publishing Group 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223868/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223868/

Similar Items